Copyright Reports & Markets. All rights reserved.

Global Cell and Gene Therapy Drug Delivery Devices Market Status and Forecast 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Status and Forecast (2016-2027)
      • 1.3.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Cell and Gene Therapy Drug Delivery Devices Supply by Company

    • 2.1 Global Cell and Gene Therapy Drug Delivery Devices Sales Volume by Company
    • 2.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Company
    • 2.3 Global Cell and Gene Therapy Drug Delivery Devices Price by Company
    • 2.4 Cell and Gene Therapy Drug Delivery Devices Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Cell and Gene Therapy Drug Delivery Devices Market Status by Type

    • 3.1 Cell and Gene Therapy Drug Delivery Devices Type Introduction
      • 3.1.1 Sterile Insulin Syringe
      • 3.1.2 Pre-Filled Syringe
      • 3.1.3 Infusion Bags
    • 3.2 Global Cell and Gene Therapy Drug Delivery Devices Market by Type
      • 3.2.1 Global Cell and Gene Therapy Drug Delivery Devices Sales Volume by Type (2016-2021)
      • 3.2.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (2016-2021)
      • 3.2.3 Global Cell and Gene Therapy Drug Delivery Devices Price by Type (2016-2021)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Cell and Gene Therapy Drug Delivery Devices Market Status by Application

    • 4.1 Cell and Gene Therapy Drug Delivery Devices Segment by Application
      • 4.1.1 Luxturna
      • 4.1.2 Kymriah
      • 4.1.3 Provenge
      • 4.1.4 Zolgensma
      • 4.1.5 Yescarta
      • 4.1.6 Strimvelis
    • 4.2 Global Cell and Gene Therapy Drug Delivery Devices Market by Application
      • 4.2.1 Global Cell and Gene Therapy Drug Delivery Devices Sales Volume by Application (2016-2021)
      • 4.2.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (2016-2021)
      • 4.2.3 Global Cell and Gene Therapy Drug Delivery Devices Price by Application (2016-2021)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Cell and Gene Therapy Drug Delivery Devices Market Status by Region

    • 5.1 Global Cell and Gene Therapy Drug Delivery Devices Market by Region
      • 5.1.1 Global Cell and Gene Therapy Drug Delivery Devices Sales Volume by Region
      • 5.1.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Region
    • 5.2 North America Cell and Gene Therapy Drug Delivery Devices Market Status
    • 5.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Status
    • 5.4 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Status
    • 5.5 Central & South America Cell and Gene Therapy Drug Delivery Devices Market Status
    • 5.6 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Status

    6 North America Cell and Gene Therapy Drug Delivery Devices Market Status

    • 6.1 North America Cell and Gene Therapy Drug Delivery Devices Market by Country
      • 6.1.1 North America Cell and Gene Therapy Drug Delivery Devices Sales Volume by Country (2016-2021)
      • 6.1.2 North America Cell and Gene Therapy Drug Delivery Devices Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Cell and Gene Therapy Drug Delivery Devices Market Status

    • 7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market by Country
      • 7.1.1 Europe Cell and Gene Therapy Drug Delivery Devices Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Cell and Gene Therapy Drug Delivery Devices Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Status

    • 8.1 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market by Country
      • 8.1.1 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Cell and Gene Therapy Drug Delivery Devices Market Status

    • 9.1 Central & South America Cell and Gene Therapy Drug Delivery Devices Market by Country
      • 9.1.1 Central & South America Cell and Gene Therapy Drug Delivery Devices Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Cell and Gene Therapy Drug Delivery Devices Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Status

    • 10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market by Country
      • 10.1.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Cell and Gene Therapy Drug Delivery Devices Manufacturing Cost Analysis
    • 11.5 Cell and Gene Therapy Drug Delivery Devices Sales Channel and Distributors Analysis
      • 11.5.1 Cell and Gene Therapy Drug Delivery Devices Sales Channel
      • 11.5.2 Cell and Gene Therapy Drug Delivery Devices Distributors
    • 11.6 Cell and Gene Therapy Drug Delivery Devices Downstream Major Buyers

    12 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Type and by Application

    • 12.1 Global Cell and Gene Therapy Drug Delivery Devices Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Cell and Gene Therapy Drug Delivery Devices Forecast by Type
      • 12.2.1 Global Cell and Gene Therapy Drug Delivery Devices Sales Volume Forecast by Type
      • 12.2.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Value Forecast by Type
      • 12.2.3 Global Cell and Gene Therapy Drug Delivery Devices Price Forecast by Type
    • 12.3 Global Cell and Gene Therapy Drug Delivery Devices Forecast by Application
      • 12.3.1 Global Cell and Gene Therapy Drug Delivery Devices Sales Volume Forecast by Application
      • 12.3.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Value Forecast by Application
      • 12.3.3 Global Cell and Gene Therapy Drug Delivery Devices Price Forecast by Application

    13 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Region/Country

    • 13.1 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Region (2022-2027)
      • 13.1.1 Global Cell and Gene Therapy Drug Delivery Devices Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Vericel Corporation
      • 14.1.1 Company Information
      • 14.1.2 Cell and Gene Therapy Drug Delivery Devices Product Introduction
      • 14.1.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 uniQure N.V.
      • 14.2.1 Company Information
      • 14.2.2 Cell and Gene Therapy Drug Delivery Devices Product Introduction
      • 14.2.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Spark Therapeutics, Inc.
      • 14.3.1 Company Information
      • 14.3.2 Cell and Gene Therapy Drug Delivery Devices Product Introduction
      • 14.3.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Renova Therapeutics
      • 14.4.1 Company Information
      • 14.4.2 Cell and Gene Therapy Drug Delivery Devices Product Introduction
      • 14.4.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Pfizer, Inc.
      • 14.5.1 Company Information
      • 14.5.2 Cell and Gene Therapy Drug Delivery Devices Product Introduction
      • 14.5.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Orchard Therapeutics plc.
      • 14.6.1 Company Information
      • 14.6.2 Cell and Gene Therapy Drug Delivery Devices Product Introduction
      • 14.6.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Novartis AG
      • 14.7.1 Company Information
      • 14.7.2 Cell and Gene Therapy Drug Delivery Devices Product Introduction
      • 14.7.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Kolon Tissue Gene, inc.
      • 14.8.1 Company Information
      • 14.8.2 Cell and Gene Therapy Drug Delivery Devices Product Introduction
      • 14.8.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Kite Pharma, Inc.
      • 14.9.1 Company Information
      • 14.9.2 Cell and Gene Therapy Drug Delivery Devices Product Introduction
      • 14.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Human Stem Cell Institute
      • 14.10.1 Company Information
      • 14.10.2 Cell and Gene Therapy Drug Delivery Devices Product Introduction
      • 14.10.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Helixmith Co., Ltd (ViroMed Co., Ltd)
    • 14.12 Dendreon Pharmaceuticals LLC.
    • 14.13 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
    • 14.14 Bluebird bio, Inc.
    • 14.15 Becton, Dickinson and Company
    • 14.16 Bausch and Lomb Incorporated
    • 14.17 Amgen, Inc.

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Cell and Gene Therapy Drug Delivery Devices market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Cell and Gene Therapy Drug Delivery Devices industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Cell and Gene Therapy Drug Delivery Devices market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Cell and Gene Therapy Drug Delivery Devices Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Cell and Gene Therapy Drug Delivery Devices market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Cell and Gene Therapy Drug Delivery Devices Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Cell and Gene Therapy Drug Delivery Devices industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Sterile Insulin Syringe
      Pre-Filled Syringe

      Segmented by Application
      Luxturna
      Kymriah
      Provenge
      Zolgensma
      Yescarta
      Strimvelis

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Spark Therapeutics, Inc.
      Renova Therapeutics
      Pfizer, Inc.
      Orchard Therapeutics plc.
      Novartis AG
      Kolon Tissue Gene, inc.
      Kite Pharma, Inc.
      Human Stem Cell Institute
      Helixmith Co., Ltd (ViroMed Co., Ltd)
      Dendreon Pharmaceuticals LLC.
      Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
      Bluebird bio, Inc.
      Becton, Dickinson and Company
      Bausch and Lomb Incorporated
      Amgen, Inc.
      Buy now